Topics Included: Patient Engagement
SHARE TO:
ATTENTION Patients, Caregivers and Advocates: The FDA and CTTI will not be accepting applications for the Patient Engagement Collaborative (PEC) this year. We are maintaining our current membership for 2026. We value the patient voice and perspective and are exploring other options and ideas to increase patient engagement more broadly at the FDA. If you have any questions, please email: PatientEngagementCollaborative@fda.hhs.gov.
The Patient Engagement Collaborative (PEC) is a joint project between the U.S. Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI). The PEC is an ongoing, shared setting in which the patient community (PEC members), FDA, and CTTI discuss many topics for improving communication, education, and patient engagement related to medical product regulation. Click here to review the PEC Framework.
Resources
Patient Engagement | CTTI News
Patient Engagement Collaborative Announces Eight New Members
Today, the U.S. Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI) announced eight newly selected representatives for the Patient Engagement Collaborative (PEC).
Patient Engagement | Press Releases
CTTI and the FDA Select Representatives for Patient Engagement Collaborative
CTTI Project: Patient Engagement Collaborative The Clinical Trials Transformation Initiative (CTTI) and the U.S. Food and Drug Administration (FDA) announced newly selected representatives for the Patient Engagement Collaborative (PEC) today....
Patient Engagement | Press Releases
CTTI Selected to Support FDA Efforts to Increase Patient Engagement Through New Collaborative
CTTI has been engaged by the U.S. Food and Drug Administration (FDA) to support its Patient Engagement Collaborative (PEC), an effort created in partnership with CTTI to bring together members...
Patient Engagement | Press Releases
Clinical Trials Transformation Initiative (CTTI) Forms Patient Leadership Council to Help Drive Improvements in Clinical Trials
As part of an effort to improve the way clinical trials are conducted, the Clinical Trials Transformation Initiative (CTTI) has formed a 16-member council to engage patient advocates in its...
Patient Engagement | CTTI News
Now Accepting Applications for FDA and CTTI Patient Engagement Collaborative (PEC)
The FDA and CTTI are currently accepting applications from patient advocates interested in becoming members of the Patient Engagement Collaborative (PEC).
CTTI News
Now Accepting Applications for FDA and CTTI Patient Engagement Collaborative (PEC)
The FDA and CTTI are currently accepting applications from patient advocates interested in becoming members of the Patient Engagement Collaborative (PEC). The PEC is an ongoing, shared forum in which...
Patient Engagement | CTTI News
Patient Engagement Collaborative (PEC) Application to Open Soon
The FDA and CTTI will be accepting applications this summer from patient community representatives interested in becoming members of the Patient Engagement Collaborative (PEC). The PEC is an ongoing, shared...
Patient Engagement | Resources
PEC Meeting Summary – February 2024
PEC Meeting Summary – February 2024
Patient Engagement | Resources
PEC Meeting Summary – November 2023
PEC Meeting Summary – November 2023
Patient Engagement | Resources
PEC Meeting Summary – September 2023
PEC Meeting Summary – September 2023
Patient Engagement | Resources
PEC Meeting Summary – February 2023
PEC Meeting Summary - February 2023
Patient Engagement | CTTI News
Patient Engagement Collaborative Announces Eight New Members
Today, the U.S. Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI) announced eight newly selected representatives for the Patient Engagement Collaborative (PEC). The group of 16...
Patient Engagement | Resources
PEC Meeting Summary – September 2022
PEC Meeting Summary - September 2022
Patient Engagement | CTTI News
FDA, CTTI Accepting Applications for Patient Engagement Collaborative (PEC)
The FDA and CTTI are currently accepting applications from patient advocates interested in becoming members of the Patient Engagement Collaborative (PEC). The PEC is an ongoing, collaborative forum where patient...
Patient Engagement | Resources
PEC Meeting Summary – January 2022
PEC Meeting Summary - January 2022
Patient Engagement | CTTI News
Patient Engagement Collaborative Announces Eight New Members
Today, the U.S. Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI) announced eight newly selected representatives for the Patient Engagement Collaborative (PEC). The group of 16...
Patient Engagement | CTTI News
FDA, CTTI Accepting Applications for Patient Engagement Collaborative (PEC)
The FDA and CTTI are currently accepting applications from patient advocates interested in becoming members of the Patient Engagement Collaborative (PEC). The PEC is an ongoing, collaborative forum that brings the patient...
Patient Engagement | Resources
PEC Meeting Summary – October 2020
PEC Meeting Summary - October 2020
Patient Engagement | CTTI News
Now Available: Summary of the September Patient Engagement Collaborative Meeting
A summary of the most recent meeting of the Patient Engagement Collaborative (PEC) is now available. The PEC, which is convened jointly by the FDA and CTTI to discuss how the FDA...
Patient Engagement | CTTI News
FDA Patient Engagement Efforts Highlighted in CTTI-hosted Webinar
Are you curious about what the FDA is doing to integrate patient engagement throughout the agency? Wondering how CTTI is collaborating on some of these efforts? Learn about a variety...
Patient Engagement | Resources
PEC Meeting Summary – September 2019
PEC Meeting Summary - September 2019
Patient Engagement | CTTI News
Now Available: Summary of the March Patient Engagement Collaborative Meeting
The FDA, in collaboration with CTTI, convened the second in-person meeting of the Patient Engagement Collaborative (PEC) in March at the FDA’s White Oak Campus in Silver Spring, Md. A summary of...
Patient Engagement | CTTI News
Now Available: Summary of the Patient Engagement Collaborative Inaugural Meeting
The FDA, in collaboration with CTTI, convened the inaugural meeting of the newly formed Patient Engagement Collaborative (PEC) in August at the FDA’s White Oak Campus in Silver Spring, Md. A summary...
Patient Engagement | CTTI News
Sixteen Representatives Selected for the Patient Engagement Collaborative at FDA
CTTI and the FDA recently announced newly selected representatives for the Patient Engagement Collaborative (PEC), a joint endeavor announced in December 2017 to gather members of the patient community to...
Safety | CTTI News
Four Key Areas Where CTTI Has Transformed Clinical Trials
This year, CTTI marks its 10th year of working with a variety of stakeholders to positively change clinical trials, making them more streamlined, efficient, and patient-focused. To commemorate this milestone, we...
Patient Engagement | CTTI News
CTTI Selected to Support FDA Efforts to Increase Patient Engagement Through New Collaborative
CTTI has been engaged by the U.S. Food and Drug Administration (FDA) to support its Patient Engagement Collaborative (PEC), an effort created in partnership with CTTI to bring together members...
Patient Engagement | CTTI News
FDA and CTTI to Collaborate on New Patient Engagement Initiative
The FDA and the Clinical Trials Transformation Initiative (CTTI) will be collaborating to establish a new external work group related to patient engagement at the FDA. The FDA has long...